Reply
Anna Linda Zignego, Laura Gragnani, Loreta A. Kondili – 25 February 2022
Reply
Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong – 25 February 2022
Letter to the editor: Using angiotensin‐converting enzyme inhibitors to prevent liver‐related events in NAFLD—Revisiting the renin–angiotensin–aldosterone system pathways
Manas Kumar Panigrahi, Prajna Anirvan – 25 February 2022
Dual roles of B lymphocytes in mouse models of diet‐induced nonalcoholic fatty liver disease
Martin Karl, Solveig Hasselwander, Yawen Zhou, Gisela Reifenberg, Yong Ook Kim, Kyoung‐Sook Park, Dirk A. Ridder, Xiaoyu Wang, Eric Seidel, Nadine Hövelmeyer, Beate K. Straub, Huige Li, Detlef Schuppan, Ning Xia – 25 February 2022
Seeking editor for Clinical Liver Disease
23 February 2022
Reply
Ji Zhang, Tingting Zhao, Lai Wei, Yuzhang Wu – 23 February 2022
Issue Information
23 February 2022
Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models
Tomasz J. Czernuszewicz, Adam M. Aji, Christopher J. Moore, Stephanie A. Montgomery, Brian Velasco, Gabriela Torres, Keerthi S. Anand, Kennita A. Johnson, Allison M. Deal, Dženan Zukić, Matthew McCormick, Bernd Schnabl, Caterina M. Gallippi, Paul A. Dayton, Ryan C. Gessner – 23 February 2022 – Shear wave elastography (SWE) is an ultrasound‐based stiffness quantification technology that is used for noninvasive liver fibrosis assessment.
Letter to the editor: Beneath the surface of the pandemic: Persons with alcohol‐associated liver disease need our attention
Salah Kivlighn, Eric Schuur, Robert G. Gish, Donna Cryer – 23 February 2022
Hepatocelluar Carcinoma Risk in Advanced Fibrosis After Sustained Virologic Response: When Can We Safely Stop Hepatocellular Carcinoma Surveillance?
Masaru Enomoto, Philip Vutien, Norifumi Kawada – 23 February 2022